Weight Loss
Medical weight management with access to FDA-approved GLP-1 medications and other therapies, if prescribed.
FDA-Approved Options
Start with clinician-evaluated access to FDA-approved GLP-1 medications and other established therapies. Pricing varies based on treatment plan, medication, and eligibility.
Foundayo™ (Orforglipron)
OralFDA-approvedFDA-approved once-daily oral GLP-1 treatment. Available if clinically appropriate.
Oral
Oral Semaglutide (Wegovy Pill)
OralFDA-approvedThe branded Wegovy pill — prescription-strength semaglutide without injections.
Injectable
V
Wegovy / Zepbound Access
InjectableFDA-approvedBranded injectable GLP-1 access may be discussed when clinically appropriate, including manufacturer-direct or retail-pharmacy fulfillment pathways.
Personalized / Alternative Options
Additional approaches may be considered case by case
In certain clinician-determined, patient-specific cases, additional treatment approaches may be considered. These may include compounded medications or other individualized therapies when appropriate.
These options are not presented as standard products, are not guaranteed to be available, and may not be appropriate for every patient or every state.
Important safety information for GLP-1 treatments
- Semaglutide and orforglipron carry boxed-warning considerations related to thyroid C-cell tumors and are contraindicated in patients with a personal or family history of MTC or MEN2.
- Common side effects can include nausea, vomiting, diarrhea, and constipation. Individual results may vary.
- Varus emphasizes FDA-approved options where clinically appropriate. Compounded semaglutide is not FDA-approved, should not be presented as equivalent to any FDA-approved brand product, and should be considered only in limited patient-specific circumstances.